Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl oxime-piperazines useful as CCR5 antagonists

Aryl oxime-piperazines useful as CCR5 antagonists

US Patent 6689783 · Granted Feb 10, 2004

Estimated economic value: $44,502,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Color conversion panel and display device2025
Bridged and fused antidiabetic compounds2016
Gamma secretase modulators2014
Tetrahydropyranochromene gamma secretase inhibitors2014
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma 2013
Gamma secretase modulators2013
Gamma secretase modulators2013
Gamma secretase modulators2013
Piperazine derivatives useful as CCR5 antagonists2012
Piperazine derivatives useful as CCR5 antagonists2012
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma 2011
Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors2011